CAR-T
-
Lupus and lupus nephritis
The most developed rheumatology proof of concept — with important renal distinctions.
-
Evidence atlas: read the denominator before the headline
A curated primary-source map, not a pooled response estimate.
-
The platform map: CAR-T is not one treatment
Separate the source of cells, the engineering method, persistence and treatment setting.
-
CD19, BCMA and the choice of target
Which cellular compartment is being addressed — and which may remain?
-
What an immune “reset” would actually mean
Deep depletion is a mechanism; durable tolerance is the outcome to be demonstrated.
-
Terapia CAR-T: przewodnik dla pacjentów i bliskich
Realne nadzieje, ważne pytania i bardziej świadoma rozmowa z zespołem leczącym.
-
Terapia CAR-T: guía para pacientes y familias
Una promesa real, preguntas importantes y una conversación más clara con el equipo médico.
-
CAR-T-терапия: для пациентов и близких
Реальные перспективы, важные вопросы и понятный разговор с лечащей командой.
-
CAR-T therapy: a patient and family guide
Real promise, important questions, and a clearer conversation with your care team.
-
Why the promise is real
From repeated suppression toward treatment-free control — with the evidence kept in focus.